首页 | 本学科首页   官方微博 | 高级检索  
     

小檗碱通过ERK,JNK信号转导途径对COX-2的抑制作用
引用本文:王启章,郭毅,韩利民,黄术良,张艳波. 小檗碱通过ERK,JNK信号转导途径对COX-2的抑制作用[J]. 医学争鸣, 2009, 30(24): 2935-2939
作者姓名:王启章  郭毅  韩利民  黄术良  张艳波
作者单位:广州医学院附属深圳沙井医院神经内科,广东,深圳,518104;暨南大学第二临床医学院神经内科,广东,深圳,518020
摘    要:目的:研究中药小檗碱是否通过ERK,JNK信号转导途径抑制人外周血单核细胞COX-2mRNA及蛋白表达.方法:取人外周静脉血分离及培养单核细胞,分为对照组、LPS组、LPS+小檗碱25μmol/L组、LPS+小檗碱50μmol/L组、LPS+小檗碱100μmol/L组.分别在培养后30min,6,12,24h提取细胞,行RT-PCR法测定COX-2mRNA水平,行Western Blot法测定ERK,p-ERK,JNK,p-JNK及COX-2蛋白水平.同时加入选择性ERK,JNK抑制剂,分别测定COX-2mRNA及蛋白水平.结果:与LPS组相比,小檗碱组COX-2mRNA及蛋白表达明显抑制(P〈0.05).与LPS组相比,小檗碱组ERK活性水平有统计学差异(P〈0.05).但是与LPS组相比,低、中浓度小檗碱组(25,50μmol/L)JNK活性水平无统计学差异,高浓度小檗碱组(100μmol/L)JNK活性水平有明显统计学差异(P〈0.05).加入ERK,JNK抑制剂之后,COX-2mRNA及蛋白水平降低明显(P〈0.05).结论:小檗碱能抑制人外周血单核细胞COX-2mRNA及蛋白水平,其作用程度呈浓度依赖性.小檗碱可能通过ERK信号转导途径抑制人外周血单核细胞COX-2mRNA及蛋白表达.高浓度小檗碱可能通过JNK信号转导途径抑制人外周血单核细胞COX-2mRNA及蛋白表达.

关 键 词:小檗碱  ERK  JNK  COX-2  动脉粥样硬化

Berberine inhibits lipopolysaccharide induced COX-2 expression via ERK signaling cascade pathways in human peripheral blood monocytes
WANG Qi-Zhang,GUO Yi,HAN Li-Min,HUANG Shu-Liang,ZHANG Yan-Bo. Berberine inhibits lipopolysaccharide induced COX-2 expression via ERK signaling cascade pathways in human peripheral blood monocytes[J]. Negative, 2009, 30(24): 2935-2939
Authors:WANG Qi-Zhang  GUO Yi  HAN Li-Min  HUANG Shu-Liang  ZHANG Yan-Bo
Affiliation:WANG Qi-Zhang1,GUO Yi2,HAN Li-Min1,HUANG Shu-Liang2,ZHANG Yan-Bo2 1Department of Neurology,Shenzhen Shajing Affiliated Hospital,Guangzhou Medical University,Shenzhen 518104,China,2Department of Neurology,Second Clinical Medical College,Ji'nan University,Shenzhen 518020
Abstract:AIM: To investigate the inhibition of berberine (BBR) on lipopolysaccharide (LPS)induced COX-2 expression via ERK signaling cascade pathways in human peripheral blood monocytes(HPMC). METHODS: HPMC were isolated and cultured from whole blood and divided into 5 groups treated with null, LPS, LPS + BBR 25 μmol/L, LPS + BBR 50 μmol/L, LPS + BBR 100 μmol/L respectively for 30 rain, 6,12 and 24 h. Then monocytes were extracted for RT-PCR and westernblot analysis to examine COX-2 mRNA and protein activated expression of ERK signaling pathway. Meanwhile, ERK and inhibitor was incubated together with LPS stimulation to examine COX2 mRNA and protein expression. RESULTS: At the four time points after treatment, the COX-2 mRNA and protein expression decreased at a low ebb at 12 h after BBR treatment(P 〈 0.05). In the group of BBR treatment at various time points ( at 6,12,24 h after treatment) and three levels of dosage, ERK protein expression was inhibited significantly. At the concentration of 25 and 50 μmol/L, JNK protein expression was not inhibited significantly by BBR compared with LPS stimulation group ( P 〉 0.05 ). Whereas with the treatment of BBR at the concentration of 100 μmol/L, JNK protein expression could be inhibited obviously compared with LPS stimulation group ( P 〈 0.01 ). Hmnan monoeytes COX-2 mRNA and protein expression was inhibited statistically significantly while incubated with ERK and JNK pathway inhibitor, PD98059 (P 〈 0.01). CONCLUSION: We conclude that BBR inhibits COX-2 mRNA and protein expression in a dose-dependent manner and ERK expression could be suppressed by BBR. BBR may inhibit COX-2 expression via ERK signaling pathway in HPMC. High concentration of BBR may inhibit COX-2 expression via JNK sig- naling pathway in HPMC.
Keywords:BBR  COX-2  ERK  JNK  atherosclerosis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号